For Research Use Only · Not For Human or Veterinary Use · Not FDA-Approved

Protocol

Tirzepatide reconstitution protocol

Step-by-step reconstitution and storage parameters for tirzepatide lyophilized vials. Reference values derived from published handling literature.

— Research reconstitution calculator

Tirzepatide

Reference math for research handling. Not a dosing recommendation.

IntensityDoseDrawFrequency
maintenance2.5 mg0.5 mLOnce weekly SC
standard7.5 mg1.5 mLOnce weekly SC
aggressive15 mg3 mLOnce weekly SC

Intensities summarized from published literature — not a dosing recommendation. For research use only. Not for human or veterinary use.

This protocol describes the reconstitution and storage of lyophilized tirzepatide in standard research workflows. All values are derived from published compound-handling literature and from the parameters used in major clinical research protocols. Selection of any specific concentration or interval is the responsibility of the qualified investigator.

At a glance

Parameter Value
Recommended diluent Bacteriostatic Water (USP, 0.9% benzyl alcohol)
Recommended volume (10 mg vial) 2.0 mL
Final concentration 5 mg/mL
Stability — lyophilized ≥24 months at -20 °C, light-protected, sealed
Stability — reconstituted 30 days at 2–8 °C in original vial
Freeze-thaw Avoid on reconstituted solution. Aliquot if longer-term storage needed.

Procedure

  1. Equilibrate. Allow the sealed vial to come to room temperature before reconstitution. Cold glass + cold diluent can produce condensation on the stopper.
  2. Sterile prep. Wipe the stopper with isopropyl alcohol and allow to dry. Use a sterile syringe and a 21G or larger needle for transfer.
  3. Inject diluent slowly. Direct the stream of bacteriostatic water along the inner glass wall — not directly onto the lyophilized cake. Rapid injection onto the cake can foam the compound and damage structure.
  4. Dissolve gently. Swirl the vial in a slow rotational motion. Do not shake. The lyophilized cake should dissolve within 30–60 seconds.
  5. Verify. Solution should be clear and colorless. If cloudy, particulate, or discolored, do not use — contact Merit (info@meritpeptides.com) with the lot number.

Storage

Reconstituted tirzepatide is stable for approximately 30 days at 2–8 °C when kept in the original vial. The benzyl alcohol in bacteriostatic water acts as a preservative against microbial growth during this period. Light-protect the vial (most vial stoppers are partially light-permeable).

For storage longer than 30 days, aliquot into sterile single-use tubes and freeze at -20 °C or colder. Avoid freeze-thaw cycles — each cycle introduces degradation. Lyophilized (pre-reconstitution) stability is significantly longer: at least 24 months at -20 °C light-protected.

What you'll need

  • Sterile bacteriostatic water (USP) — typically 30 mL multi-dose vial
  • Sterile syringes (1 mL or 3 mL) with appropriate-gauge needles
  • Isopropyl alcohol wipes (70%)
  • Sharps disposal container
  • Sterile aliquot tubes if extended freezer storage is planned

Notes

This protocol describes reconstitution parameters used in published compound-handling literature. It is not a recommendation for any particular study design or application. Selection of concentration, interval, and route is the responsibility of the qualified investigator under appropriate institutional oversight. For research use only. Not for human or veterinary use.

References

  1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205–216. PMID: 35658024
  2. Coskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus. Mol Metab 2018;18:3–14. PMID: 30473097

For research use only. Not for human or veterinary use. Not FDA-approved. Reference information summarized from published literature — not medical or dosing advice.